RBC Capital Maintains Sector Perform on Aurinia Pharmaceuticals, Raises Price Target to $16

Benzinga · 1d ago
RBC Capital analyst Douglas Miehm maintains Aurinia Pharmaceuticals (NASDAQ:AUPH) with a Sector Perform and raises the price target from $15 to $16.